Targets for Detection of Ischemia
OwnerHollie Huff, Shannon George +1inventors
InventorsHollie Huff, Shannon George, Ping Wu
Life of this patent
Estimating the term…
Loading patent…
OwnerHollie Huff, Shannon George +1inventors
InventorsHollie Huff, Shannon George, Ping Wu
Estimating the term…
The subject application comprises methods for determining the occurrence of an ischemic event in a subject by determining an ischemia score based on the amount of at least two ischemia modified albumin markers. The ischemia modified albumin markers include complexes of fatty acids bound to albumin, albumin molecules with open Cys34 sites, albumin molecules that are products of oxidation at Cys34, albumin molecules with altered conformation or altered divalent metal binding due to the conformational change or oxidation at Cys34, and albumin molecules that have been oxidized at the N-terminus. Also included in the invention are ligands to each of the foregoing ischemia modified albumin markers. Further included are methods of determining the occurrence of an ischemic event by determining the amount of fatty acid that is complexed to albumin in a patient sample. In another embodiment, an ischemic event is determined by quantitating the relative amounts of reduced and oxidized forms of albumin Cys34. In an additional embodiment, an ischemic event is determined by observing whether a shift in albumin conformation has occurred which would reflect oxidized Cys34. Further, the invention comprises a method of determining an ischemic event by determining the amount of metal ion bound to the albumin metal ion binding sites.
A method comprising:
A method comprising:
A ligand that is specific to a complex of fatty acid and albumin.
A ligand that is specific to an albumin molecule with an exposed Cys34 site.
A ligand that is specific to an albumin molecule that is a product of an oxidation reaction at Cys34.
A ligand that is specific to an albumin molecule that has an altered conformation or reduced divalent metal binding due the conformational change at Cys34.
A ligand that is specific to an albumin molecule that has 2-oxo-histidine at His3 and/or His9.
A method comprising:
A method comprising:
A method comprising:
A method of detecting or measuring an ischemic event comprising the steps of:
Dependencies are inferred from the claim text.